Introduction
Various gene transfer methods have been developed to introduce genes into the liver. Although viral vector systems are highly efficient in gene transfer, there are serious problems such as the possibility of insertional mutagenesis and the induction of the host immune responses. [1] [2] [3] [4] Among the nonviral vector systems, the direct injection of plasmid DNA or hemagglutinating virus of Japan (HVJ) liposome is a safe and simple technique. [5] [6] [7] [8] However, the efficiency of gene expression is low. In other words, there are some unsolved problems for gene transfer methods such as low transfection efficiency and safety in all of these methods. From this point of view, it is necessary to establish the safe and efficient nonviral gene transfer methods.
There have been some reports on gene transfer into the rodent liver using electroporation combined with the direct injection of plasmid DNA into the liver tissue. [9] [10] [11] However, with this technique, transgene expression was observed in a limited area of the liver around the injected site of DNA. Moreover, liver tissue damage may be caused mechanically by the needle. Therefore, to obtain diffuse gene expressions in the liver and to avoid tissue damage by the needle, we developed a modified method of gene transfer into the liver by infusion of plasmid DNA via the portal vein followed by electroporation.
Hepatocyte growth factor (HGF), first identified as a potent mitogen for mature hepatocytes, [12] [13] [14] has been reported to have multiple biological properties, including mitogenic, morphogenic, [15] [16] [17] and antiapoptic activity for a wide variety of cells. 18, 19 HGF plays an important role in liver regeneration. [20] [21] [22] Several studies of HGF given to prevent various types of liver injury in vivo and in vitro have shown the potential therapeutic effects against the liver injury. [23] [24] [25] Recently, repeated HGF gene transfer using HVJ liposome has been examined in a rat model of liver cirrhosis, and attenuated the liver cirrhosis. 26, 27 In the present study, we investigated whether or not HGF gene transfer into the liver via the portal vein using electroporation attenuates the rat liver cirrhosis (Figure 1 ).
Results

Green fluorescence protein expression in the liver
At 3 days after green fluorescence protein (GFP) gene transfer, GFP expression in the electroporated area of the liver was more detected with the injection of 500 mg of GFP gene (n¼5) than with that of 100 mg of GFP gene (n¼5). However, it was not detected at all in the liver injected with phosphate-buffered saline (PBS) alone (n¼5) (Figure 2 ). After transfection, these expressions were detected in 24 h, and then maximally at 3 days, and persisted for 3 weeks. On the other hand, GFP expression was slightly detected in the nonelectroporated area of the liver.
Examination on the liver damage induced by electroporation
Histologically, mild degrees of liver damage and influx of inflammatory cells were induced in the electroporated area at 1 and 3 days after electroporation (Figure 3b, c) . However, these damages were diminished at day 7 ( Figure 3d ). On the other hand, the liver damage was not induced at all in the nonelectroporated area. Biochemically, at 1 day after electroporation, there was a transient increase in the serum aspartate aminotransferase and alanine aminotransferase in the rats that were electroporated (n¼5) or nonelectroporated (n¼5). These levels returned to within the normal range by day 7. Moreover, these levels were not significantly different at any time points after electroporation (Table 1) .
Enzyme-linked immunosorbent assay for human HGF
At 3 days after human HGF gene transfer, in the electroporated area, human HGF was significantly detected in the liver injected with 500 mg of human HGF gene (n¼5; 1.9471.38 ng/ml), as compared with the liver injected with 100 mg of human HGF gene (n¼5; 0.1170.02 ng/ml) and the liver injected with PBS alone (n¼5; below the limit of detection) (Po0.05; Figure 4 ). In contrast, the serum level of human HGF was below the limit of detection in all groups. On the other hand, in the nonelectroporated area, human HGF was slightly detected in the liver injected with 500 mg of human HGF gene (n¼5; 0.1370.04 ng/ml), as compared with the liver injected with 100 mg of human HGF gene (n¼5; below the limit of detection).
Effects of HGF for the rat liver cirrhosis model
All untreated rats (Group 1; n¼6) and PBS-treated rats (Group 2; n¼5) died of severe liver cirrhosis within 41 days during dimethylnitrosamine (DMN) treatment ( Figure 5 ) (Group 1: median survival was 36 days; Group 2: median survival was 34 days). In contrast, all rats transfected with 500 mg of human HGF gene (Group 3; n¼6) survived more than 50 days (Po0.001, compared with untreated and PBS-treated rats) ( Figure 6 ).
Histological examination for liver cirrhosis
In the livers that were untreated (n¼3) or treated with PBS (n¼3) at 5 weeks after DMN treatment began, fibrous tissue components in Glisson's sheath and pseudonodule formations were observed. Moreover, there were infiltrating mononuclear cells and bridging necrosis between Glisson's sheath and the central veins in the liver. In contrast, in the liver treated with 500 mg of human HGF gene (n¼3), fibrous regions and pseudonodule formations were mostly diminished. Moreover, infiltrating mononuclear cells were scarcely seen ( Figure 7 ). Quantitative analysis of fibrosis by image analysis techniques showed that fibrotic rate (%) was significantly reduced in the electroporated area (n¼3; 4.770.6 %) and in the nonelectroporated area (n¼3; 4.970.6%) of the liver from rats treated with 500 mg of HGF gene, compared with that in the electroporated area (n¼3; 15.270.5%) and in the nonelectroporated area (n¼3; 15.371.1%) of the liver from rats treated with PBS (Po0.05). However, the fibrosis of the liver treated with 
Discussion
There are viral and nonviral systems as in vivo gene transfer methods. Among the viral vector systems, retroviral vectors have been used for gene delivery into rat livers after partial hepatectomy. 28 In this model, 1-5% of hepatocytes were transfected. Adenoviral vectors could induce efficient gene expressions in hepatocytes in vivo, but these vectors led to transient expression in addition to cytotoxity and immune responses. [1] [2] [3] [4] 29, 30 On the other hand, as nonviral vector systems, there have been some reports on the HVJ liposome method, which is one of the nonviral vector systems and does not induce side effects. [6] [7] [8] However, the expression of the introduced gene was transient. In our previous study, we also examined in vivo gene gun-mediated gene transfer into the rat liver. However, it has some disadvantages such as the low transfection efficiency and liver tissue damage caused mechanically by helium gas. Moreover, gold particles reached only the cells on the surface area. [31] [32] [33] In other words, there have been some unsolved problems for the gene transfer method such as low transfection efficiency and safety in all of these methods. From this :HGF or PBS-portal vein injection followed by electroporation Figure 5 Experimental schedule of DMN treatment and portal vein injection of HGF gene or PBS alone followed by electroporation. After 3 weeks of DMN treatment, human HGF gene (500 mg in 1 ml) or PBS alone (1 ml) was injected into the portal vein followed by electroporation. Time (day) (after DMN administration began) Survival (%) Figure 6 Survival rate of rats that were untreated (J; n¼6), rats that were treated with PBS ('; n¼5), or rats that were treated with 500 mg of human HGF (; n¼6). Life table analyses are presented as a Kaplan-Meier plot. There have been some reports on gene transfer into the rodent liver using electroporation. [9] [10] [11] In those reports, they have applied gene transfer using electroporation combined with the direct injection of plasmid DNA into the liver tissue. With this technique, however, gene expression was observed in a limited area of the liver around its injected site. Moreover, liver tissue damage with some bleeding may be caused mechanically by the needle. Therefore, to obtain diffuse gene expression in the liver and to avoid tissue damages by the needle, we developed a modified method of gene transfer into the liver by infusion of plasmid DNA via the portal vein combined with electroporation.
To assess the efficacy of gene expression by electroporation, GFP gene (100 or 500 mg) was infused into the portal vein with electroporation, six pulses of 50 ms duration at 40 V. At 3 days after transfection, GFP expression was readily detected in the liver injected with 500 mg of GFP gene followed by electroporation, while it could be detected a little in the liver injected with 100 mg of GFP gene and not at all with PBS alone. These results suggest that GFP expressions increase in a dosedependent manner. Liu et al 34 reported as follows: 'Electroporation to the liver could be achieved through systemic administration of LacZ plasmid DNA into the tail vein and the b-gal-positive cells are mainly hepatocytes. However, the positive staining was also observed around the wall of blood vessels in some sections, which indicates that other cell types were transfected. These cells are yet to be identified.' Based on his report, in our study GFP-positive cells mainly seem to be hepatocytes. However, it is not certain whether these cells belong to hepatocytes or the other types of cells associated with the vasculature at this stage. After transfection, these expressions were detected for 3 weeks and maximally at 3 days. This transient expression for 3 weeks was one of the problems in this procedure. From point of view, the duration of foreign gene expression might depend upon a concentration of DNA, transcriptional activity of the gene promoter in the tissue environment, and many other factors. Unlike viral vectors, electroporation does not activate cellular or humoral immune responses and induce the risk of the insertional mutagenesis. 29, 30 Therefore, it is possible that sustained gene expressions may be achievable by repeated transfection.
Histological analysis revealed that liver damage was moderately induced in the liver to which electroporation was applied. Biochemically, at 1 day after electroporation, there was a transient increase in the serum level of AST and ALT in the rats that were electroporated or not. However, these levels returned to normal by day 7 after electroporation. This transient increase of the serum AST and ALT at day 1 seems to be due to the surgical procedure itself such as laparotomy or portal vein injection and not to electroporation. Therefore, this method can be applied in vivo with least damage to the liver.
Budker et al have reported that naked plasmid DNA delivered intraportally expresses efficiently in hepatocytes. 35, 36 In their report, a total of 100 mg of plasmid DNA in 1 ml was manually injected over B30 s with or without occluding the portal vein upstream from the point of injection. The gene expression was highly detected with the intraportal injection during the occlusion at the junction of the hepatic vein and caudal vena cava. Liu et al 34 reported that the highest expression of LacZ plasmid DNA was detected when DNA was injected as much as 5 min before the delivery of the electric pulses. In our study, plasmid DNA was administered intraportally within 30 s during clamping at the junction of the hepatic vein and IVC. Immediately after infusion of DNA, electroporation was applied to the liver. Then high gene expressions were detected by fluorescent microscopy.
In our second study, to investigate the efficacy of this method, we measured human immunoreactive HGF of the liver and serum in rats transfected with human HGF gene 3 days after transfection. Human HGF was detected in the liver more with administration of 500 mg of human HGF DNA than of 100 mg of human HGF gene. However, HGF in serum did not increase with 500 or 100 mg of human HGF gene. These results suggested that this method could introduce DNA directly into the target organ through the afferent vessel with temporary occlusion of the efferent vessel, although, because of no significant increase of HGF in serum, there have been no evidences to produce and release HGF into the bloodstream from the liver where high gene expression was found.
Several studies of HGF given to prevent various types of liver injury in vivo and in vitro have shown the potential therapeutic effects against liver injury.
23-25 For example, Matsuda et al 37 reported that when human recombinant HGF (50 and 200 mg/kg) was intravenously injected daily for 2 weeks following 4 weeks of DMN treatment, HGF accelerated the recovery from liver Figure 8 Assessment of fibrosis using image analysis techniques, which was calculated as the ratio of fibrosis to the whole area of the liver from rats treated with PBS or HGF gene. All rats were killed at 5 weeks after DMN treatment began. Liver samples were taken from the electroporated area and nonelectroporated area. Untreated: liver from rats administered with DMN for 5 weeks (n¼3); PBS: liver from rats treated with PBS (n¼3); HGF 500 mg; liver from rats treated with 500 mg of human HGF gene (n¼3); Normal: liver from normal rats (n¼3). Values are presented as mean7s.d. *Po0.05 versus untreated, **Po0.05 versus PBS (electroporated area), #Po0.05 versus PBS (nonelectroporated area), ##Po0.05 versus HGF 500 mg (electroporated area) and HGF 500 mg (nonelectroporated area). NS: not significant.
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cirrhosis and prevented death due to hepatic dysfunction. With this method, however, a large amount of HGF protein was required for sustaining the efficient HGF level in blood because HGF has a very short half-life (T 1/2 3-5 min). [38] [39] [40] Ueki et al reported that weekly transfection in rat skeletal muscle with 40 mg of HGF DNA using HVJ liposomes rescued all rats from fatal liver cirrhosis. 26, 27 There have been no reports that electroporation-mediated gene transfer is tested f or the treatment of liver cirrhosis. In our study, we reported that 500 mg of HGF gene transfer into the liver via the portal vein followed by electroporation could achieve the long survival of all DMN-treated rats. Moreover, fibrous regions in the liver were mostly diminished. Of particular importance is that all rats survived by only a single transfection of 500 mg of HGF gene after 4 weeks of DMN treatment, although laparotomy is required.
Our studies suggest that HGF gene transfer into the liver via the portal vein using electroporation may be one of the useful approaches because of specific gene transfer to the target organ, such as the liver, for treatment of liver diseases.
Materials and methods
Construction of nonviral DNA expression vector
To confirm the efficacy of gene expression by electroporation, pCAGGS-EGFP (enhanced green fluorescence protein) gene was used. [41] [42] [43] To produce an HGF expression vector, human HGF cDNA (2.2 kb) was inserted into the EcoRI and NotI sites of the pUC-SR a expression vector plasmid. In this plasmid, transcription of the HGF cDNA is under the control of the SR a promoter. 44 
Intraportal vein injection of plasmid DNA and electroporation in vivo
Male Sprague-Dawley rats (6-week-old) were used in this study (160-180 g; Japan SLC, Inc.). After the rats were anesthetized with diethylethel, ventral midline incisions were performed to expose the liver and the portal vein. Plasmid DNA was injected into the portal vein by using the modified method described by Budker et al. 34, 35 Briefly, a 24-gauge needle was inserted into the portal vein. The hepatic vein and caudal vena cava were temporarily clamped with a vascular clip to occlude the outflow, and the plasmid DNA (pCAGGS-EGFP: 100 and 500 mg; n¼5, respectively, or pUC-SR a/human HGF: 100 and 500 mg; n¼5, respectively) in normal saline (1 ml/rat) was manually injected into the portal vein using a 1 ml syringe within 30 s. As a negative control, 1 ml of PBS alone was injected (n¼5). Immediately after the injection, the middle lobe was held by an electrode (a pair of stainless-steel pincers of 10 mm diameter), and electric pulses were delivered to the liver by a pulse generator (Square Electroporator CUY 21; NEPA GENE, Japan) (Figure 1) . In this study, the electroporation procedure was performed at a fixed position. The electrode was placed on a single spot on the middle lobe of the liver and the six pulses were delivered at the same places on the liver. The voltage (40 V), pulse length (50 ms), and number of pulses (six times) were fixed. After electroporation, the vascular clip was declamped, and the abdominal wound was closed.
Detection of GFP expressions in the liver
The rats were killed at 3 days after 100 mg (n¼5) or 500 mg (n¼5) of GFP gene transfer. Liver samples for the assessment of GFP gene expression were taken from the electroporated area and the nonelectroporated area. Then transgene expressions were detected by fluorescent microscopy.
Examination on liver tissue damage by electroporation
The liver damage was histologically and biochemically analyzed by comparison of the rats treated with electroporation (n¼5) and without electroporation (n¼5). The rats were killed at 1, 3, and 7 days after electroporation, and the liver and blood samples were collected. Histologically, the electroporated or nonelectroporated liver was excised and immediately fixed in 10% formaldehyde, embedded in paraffin, sectioned to 5 mm, and subsequently processed for light microscopy (hematoxylin and eosin staining). Biochemically, serum activity of aspartate aminotransferase (AST) and alanine aminotransferase (ALT), a representative cytosolic enzyme of hepatocytes, was measured by a dry chemical method (Shionogi Biomed Lab. Inc., Osaka, Japan).
Enzyme-linked immunosorbent assay for human HGF
At 3 days after 100 mg (n¼5) or 500 mg (n¼5) of human HGF gene transfer, the concentration of human HGF in the liver and serum was measured by means of enzyme-linked immunosorbent assay (ELISA) using anti-human HGF monoclonal antibody (Institute of Immunology, Tokyo, Japan). 45 The antibody against human HGF reacts with only human HGF and not with rat HGF. Liver samples were taken from the electroporated area and the nonelectroporated area of the liver.
In vivo experimental design for the rat liver cirrhosis model
The physiological response to transfection of human HGF gene was also investigated in the rat liver cirrhosis model, described in a previous report 37, 46 ( Figure 5 ). Briefly, 6-week-old male Sprague-Dawley rats were used. To produce liver cirrhosis, 1% DMN (Wako Pure Chemical Industries Ltd, Tokyo, Japan) dissolved in saline was given intraperitoneally at 1 ml per kg body weight for three consecutive days per week for 4-6 weeks. At 3 weeks after DMN treatment began, rats were anesthetized with diethylethel, and pUC-SR a/human HGF vector (500 mg: 1 mg/ml) in saline (1 ml/rat) or PBS alone was injected into the portal vein followed by in vivo electroporation. Rats were divided into three groups as follows:
Group 1 (n¼6): untreated rats after DMN treatment began; Group 2 (n¼5): rats treated with PBS at 3 weeks after DMN treatment began; Group 3 (n¼6): rats treated with 500 mg of HGF gene at 3 weeks after DMN treatment began. 
Histological examination for liver cirrhosis
To evaluate the degree of liver cirrhosis, the rats were killed and the liver was excised at 5 weeks after DMN treatment began. Liver samples were taken from the electroporated area (n¼3) and the nonelectroporated area (n¼3). Excised liver tissues were fixed in 10% formaldehyde, embedded in paraffin, sectioned to 5 mm, and then stained with hematoxylin and eosin staining, and Azan Mallory staining, specifically to stain fibrous tissue components. The degree of fibrosis was assessed using image analysis techniques. Briefly, Azan-staining-positive region was selected using software Photoshop 3.0 (Adobe Systems Inc., Mountain View, CA, USA) and the positive area was measured with freeware NIH Image 1.60 (National Institute of Health, Bethesda, MD, USA). The results were expressed as a fibrotic rate (%), which was calculated as the ratio of the Azan-positive area to the total area examined. Three rats were used in each group and three specimens were obtained from each rat.
Statistical analysis
All values are expressed as mean7s.d. The statistical analysis was performed using Student's t-test. The survival curves were generated using the Kaplan-Meier method, and the differences between the curves were assessed by the log-rank test. A P-value o0.05 was considered to be statistically significant.
